MINNEAPOLIS--(BUSINESS WIRE)--Urologix®, Inc. (NASDAQ:ULGX), today reported financial results for the fiscal 2009 first quarter ended September 30, 2008. Revenue for the first quarter was $2.7 million or 39 percent less than the $4.4 million reported in the same period of fiscal 2008 and 27 percent less than the $3.7 million reported in the fourth quarter of fiscal year 2008. Net loss for the first quarter was $1.3 million, or a loss of $0.09 per diluted share. This compares to a net loss of $397,000 or $0.03 per diluted share for the first quarter of fiscal 2008, and a net loss of $2.2 million or $0.16 per diluted share in the fourth quarter of fiscal 2008. At September 30, 2008, the Company’s cash balance was $9.2 million, a decrease of $1.8 million from the prior quarter.
